Back to search results

Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types

Abroad (travel likely)Recruiting

Conditions

Clinical Stage III Cutaneous Melanoma AJCC v8 · Clinical Stage IV Cutaneous Melanoma AJCC v8 · Locally Advanced Lung Carcinoma · Locally Advanced Malignant Solid Neoplasm · Locally Advanced Melanoma · Metastatic Lung Carcinoma · Metastatic Malignant Solid Neoplasm · Metastatic Melanoma · Stage III Lung Cancer AJCC v8 · Stage IV Lung Cancer AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Mayo Clinic in Rochester, Rochester, Minnesota, United States

    Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
    Contact: Principal Investigator (Svetomir N. Markovic, MD, PhD)
Study leads

  • Svetomir N. Markovic, MD, PhD

    Principal Investigator

    Mayo Clinic in Rochester

View source on ClinicalTrials.gov(opens in a new tab)